Cargando…

In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies

Understanding the cellular underpinnings of neurodegeneration remains a challenge; loss of synapses and dendritic arborization are characteristic and can be quantified in vivo, with [(11)C]UCB-J PET and MRI-based Orientation Dispersion Imaging (ODI), respectively. We aimed to assess how both measure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mak, Elijah, Holland, Negin, Jones, P. Simon, Savulich, George, Low, Audrey, Malpetti, Maura, Kaalund, Sanne S, Passamonti, Luca, Rittman, Timothy, Romero-Garcia, Rafael, Manavaki, Roido, Williams, Guy B., Hong, Young T., Fryer, Tim D., Aigbirhio, Franklin I., O'Brien, John T, Rowe, James B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209289/ https://www.ncbi.nlm.nih.gov/pubmed/33631470 http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.016

Ejemplares similares

Molecular pathology and synaptic loss in primary tauopathies: an (18)F-AV-1451 and (11)C-UCB-J PET study
por: Holland, Negin, et al.
Publicado: (2021)

[(18)F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases
por: Mak, Elijah, et al.
Publicado: (2021)

Synaptic density in carriers of C9orf72 mutations: a [(11)C]UCB‐J PET study
por: Malpetti, Maura, et al.
Publicado: (2021)

In Vivo (18)F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy
por: Malpetti, Maura, et al.
Publicado: (2022)

Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography
por: Mak, Elijah, et al.
Publicado: (2021)

(11)C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
por: Malpetti, Maura, et al.
Publicado: (2020)

Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features
por: Low, Audrey, et al.
Publicado: (2019)

Gray matter changes related to microglial activation in Alzheimer's disease
por: Nicastro, Nicolas, et al.
Publicado: (2020)

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
por: Low, Audrey, et al.
Publicado: (2021)

Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
por: Malpetti, Maura, et al.
Publicado: (2022)

Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia
por: Malpetti, Maura, et al.
Publicado: (2023)

Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
por: Low, Audrey, et al.
Publicado: (2020)

Neuroinflammation predicts disease progression in progressive supranuclear palsy
por: Malpetti, Maura, et al.
Publicado: (2021)

In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
por: Malpetti, Maura, et al.
Publicado: (2021)

Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer’s Disease and Frontotemporal Dementia
por: Nicastro, Nicolas, et al.
Publicado: (2020)

(18)F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy
por: Nicastro, Nicolas, et al.
Publicado: (2019)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Altered structural connectivity networks in dementia with lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2021)

Correlation of microglial activation with white matter changes in dementia with Lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses
por: Bevan-Jones, W Richard, et al.
Publicado: (2017)

Early microglial activation and peripheral inflammation in dementia with Lewy bodies
por: Surendranathan, Ajenthan, et al.
Publicado: (2018)

Validation of the new pathology staging system for progressive supranuclear palsy
por: Briggs, Mayen, et al.
Publicado: (2021)

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
por: Chouliaras, Leonidas, et al.
Publicado: (2022)

Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
por: Bevan-Jones, W Richard, et al.
Publicado: (2020)

Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants
por: Street, Duncan, et al.
Publicado: (2021)

Targeted Molecular Imaging in Adrenal Disease—An Emerging Role for Metomidate PET-CT
por: Mendichovszky, Iosif A., et al.
Publicado: (2016)

Progressive supranuclear palsy: diagnosis and management
por: Rowe, James B, et al.
Publicado: (2021)

Accurate digital quantification of tau pathology in progressive supranuclear palsy
por: Pansuwan, Tanrada, et al.
Publicado: (2023)

Vascular Imaging With (18)F-Fluorodeoxyglucose Positron Emission Tomography Is Influenced by Hypoxia
por: Joshi, Francis R., et al.
Publicado: (2017)

Measuring cerebral perfusion with [(11)C]-PiB R1 in Down syndrome: associations with amyloid burden and longitudinal cognitive decline
por: Mak, Elijah, et al.
Publicado: (2020)

Detection limit of (89)Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI
por: Lechermann, Laura M., et al.
Publicado: (2020)

[(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2018)

In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
por: Bevan‐Jones, W. Richard, et al.
Publicado: (2019)

Hypoxia and tissue destruction in pulmonary TB
por: Belton, Moerida, et al.
Publicado: (2016)

(18)F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2017)

[(18)F]AV‐1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
por: Bevan‐Jones, Richard W., et al.
Publicado: (2018)

Speaker 1: John O’Brien, UK
por: O’Brien, John T, et al.
Publicado: (2016)

Structural correlates of survival in Progressive Supranuclear Palsy
por: Street, Duncan, et al.
Publicado: (2023)

[(11)C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease
por: van den Ameele, Jelle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6h8a8lvq8ojbi9k2uq1jc7kale